Skip to content

Based on my review of the GO-CAM model gomodel:66a3e0bb00002890 and related information, I can provide the following quality control assessment:

GO-CAM Model Review: gomodel:66a3e0bb00002890

Overview

  • Title: Thrombopoietin-mediated signaling pathway (Human)
  • Taxon: Homo sapiens (NCBITaxon:9606)
  • Status: Production
  • ID: gomodel:66a3e0bb00002890

Summary

This GO-CAM model represents the thrombopoietin (TPO) signaling pathway in humans through the TPO receptor (MPL), illustrating a canonical cytokine signaling cascade through JAK2 and STAT5A. The model captures a linear causal sequence from TPO binding to its receptor, subsequent activation of JAK2 kinase, and ultimately STAT5A-mediated transcriptional regulation.

Model Structure and Content

The model consists of 4 key molecular activities, all part of the thrombopoietin-mediated signaling pathway (GO:0038163):

  1. TPO (UniProtKB:P40225) - cytokine activity (GO:0005125)
  2. Occurs in: extracellular space (GO:0005615)

  3. Causal relation: directly positively regulates MPL activity

  4. MPL/TPO Receptor (UniProtKB:P40238) - thrombopoietin receptor activity (GO:0038164)

  5. Occurs in: plasma membrane (GO:0005886)

  6. Causal relation: directly positively regulates JAK2 activity

  7. JAK2 (UniProtKB:O60674) - protein tyrosine kinase activity (GO:0004713)

  8. Occurs in: cytoplasm (GO:0005737)

  9. Causal relation: directly positively regulates STAT5A activity

  10. STAT5A (UniProtKB:P42229) - DNA-binding transcription factor activity (GO:0003700)

  11. Occurs in: nucleus (GO:0005634)

Quality Control Assessment

Strengths

  1. Correct biological pathway: The model accurately represents the canonical TPO signaling pathway with appropriate causal connections between TPO, its receptor MPL, JAK2, and STAT5A.

  2. Proper localization: All components have appropriate cellular locations (TPO in extracellular space, MPL at the plasma membrane, JAK2 in cytoplasm, and STAT5A in the nucleus).

  3. Appropriate causal relationships: The model uses "directly positively regulates" (RO:0002629) relations correctly to show the direct activation sequence.

  4. Evidential support: Each activity has appropriate evidence codes and literature references.

Potential Improvements

  1. Inclusion of receptor dimerization: The current model does not explicitly capture the dimerization of MPL receptors, which is a critical mechanistic step in receptor activation. The latest research (PMID:37633268) shows that TPO bridges two MPL chains via high and low-affinity interfaces, which is important for signal transduction.

  2. JAK2 autophosphorylation: The model doesn't explicitly represent JAK2 autophosphorylation, which is a key step in JAK2 activation following receptor dimerization.

  3. STAT5 dimerization: STAT5 factors form dimers after phosphorylation by JAK2, before translocation to the nucleus. This step is not explicitly represented in the model.

  4. Missing complementary signaling pathways: TPO-MPL signaling activates multiple downstream pathways in addition to JAK-STAT, including MAPK/ERK and PI3K/AKT pathways (as evidenced in PMID:25538044), which contribute to the biological responses but aren't represented in this model.

  5. Complex representation: According to GO-CAM best practices for representing complexes, the model could potentially benefit from indicating whether activities are carried out by specific subunits or by the complex as a whole.

Literature and Evidence Consistency

The model is well-supported by the cited literature: - PMID:25538044 confirms TPO interaction with MPL and downstream signaling - PMID:8007942 validates JAK2's tyrosine kinase activity in this pathway - PMID:10502458 confirms JAK2's cytoplasmic localization - PMID:9122198 supports involvement in the TPO signaling pathway - PMID:9516478 confirms STAT5A nuclear localization - PMID:10919676 validates STAT5A's role in cytokine signaling

Recent literature (PMID:37633268) provides additional structural insights into TPO-MPL complex formation that could enhance the model.

Recommendations

  1. Add receptor dimerization: Consider representing the TPO-induced dimerization of MPL receptors based on recent structural insights (PMID:37633268).

  2. Include additional signaling branches: Add parallel signaling cascades activated by TPO-MPL, particularly the PI3K/AKT and MAPK pathways, which play important roles in TPO-mediated megakaryopoiesis and stem cell maintenance.

  3. Represent protein modifications: Include phosphorylation events of JAK2 and STAT5A as these are critical for signal transduction.

  4. Add STAT5 dimerization: Include the dimerization of STAT5 after phosphorylation by JAK2.

  5. Consider biological outcomes: Add connections to biological processes that result from this signaling pathway, such as megakaryocyte differentiation or platelet production.

Conclusion

The GO-CAM model gomodel:66a3e0bb00002890 provides a good representation of the core TPO signaling pathway. It captures the essential components and causal relationships accurately with appropriate evidence. The model could be enhanced by incorporating more detailed mechanistic steps like receptor dimerization, protein modifications, and additional signaling branches to provide a more comprehensive representation of TPO signaling and its biological outcomes.